当前位置: 首页 > 详情页

Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing Ji Shui Tan Hosp, Med Coll Peking Univ 4, Dept Endocrinol, Beijing 100035, Peoples R China; [2]Capital Med Univ, Affiliated Beijing Anzhen Hosp, Dept Urol, Beijing, Peoples R China; [3]Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [4]Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Endocrinol, Xian 710049, Peoples R China; [5]Beijing Ji Shui Tan Hosp, Med Coll Peking Univ 4, Dept Endocrinol, Xi Chen Qu Xin Jie Kou Dong Jie 31, Beijing 100035, Peoples R China
出处:
ISSN:

关键词: hypoxic inducible factor 1 alpha thyroid cancer stem cell epithelial-mesenchymal transition

摘要:
Increasing evidence has shown that cancer stem cells or tumor initiating cells are the 'root cause' of malignant cancers. However, the exact origin of cancer stem cells still remains obscure in thyroid research. EMT has been implicated in the initiation and conversion of early-stage tumors into invasive malignancies and is associated with the stemness of cancer cells. Based on these facts, a new hypothesis was suggested that EMT induces cancer stem cell generation and tumor progression in human thyroid cancer cells in vitro. In the present study, FTC133 cells identified as EMT-negative cells were used for EMT induction by HIF-1 alpha transfection. Overexpression of HIF-1 alpha induced FTC133 cells to undergo EMT, downregulated the epithelial markers E-cadherin, upregulated the mesenchymal marker vimentin, and associated with highly invasive and metastatic properties. Most importantly, the induction of EMT promoted the stem-like side population cell proportion in the FTC133 cells. These results indicate that EMT induction promotes CSC traits and cell proportions in the thyroid cancer cells, which implies that EMT could induce cancer stem cell generation and tumor progression in thyroid cancers. Further understanding of the role of EMT and cancer stem cells in cancer progression may reveal new targets for the prevention or therapy of thyroid cancers.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2011]版:
Q3 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]Beijing Ji Shui Tan Hosp, Med Coll Peking Univ 4, Dept Endocrinol, Beijing 100035, Peoples R China;
通讯作者:
通讯机构: [1]Beijing Ji Shui Tan Hosp, Med Coll Peking Univ 4, Dept Endocrinol, Beijing 100035, Peoples R China; [5]Beijing Ji Shui Tan Hosp, Med Coll Peking Univ 4, Dept Endocrinol, Xi Chen Qu Xin Jie Kou Dong Jie 31, Beijing 100035, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院